Health ❯ Healthcare ❯ Medical Research

Clinical Trials

Cancer Treatment Immunotherapy Alzheimer's Disease Gene Therapy Innovative Treatments Breast Cancer Transplantation Studies Patient Outcomes Stem Cell Therapy Drug Development

3 ARTICLES

last wk.

University of Minnesota Wins $2.2M NEI Grant to Study Fibulin-3 in Retinal Disease

Funding supports work on the retinal extracellular matrix protein fibulin-3 to guide drug testing and speed development of treatments for vision loss.

6 ARTICLES

2w ago

Remote Monitoring Fails to Cut Readmissions After Sepsis and Raises Risk for Older Adults

5 ARTICLES

2w ago

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

3 ARTICLES

2w ago

Novartis Says Del‑brax Study Met Endpoints and Reinforced Phase 3 Dosing

4 ARTICLES

3w ago

Tango’s PRMT5 Inhibitor Plus Daraxonrasib Shows 92% Response in Biomarker‑Selected Pancreatic Cancer

4 ARTICLES

3w ago

CagriSema Combo Lowers Blood Sugar and Drives Bigger Weight Loss Than Semaglutide Alone

5 ARTICLES

3w ago

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

3 ARTICLES

4w ago

Phase 1 TCER IMA401 Shows Early Safety and Tumor Responses in Solid Cancers

3 ARTICLES

4w ago

Selpercatinib Dramatically Cuts Recurrence in Early-Stage RET-Positive Lung Cancer

5 ARTICLES

4w ago

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

3 ARTICLES

4w ago

Teclistamab Significantly Lengthens Remissions and Survival in Relapsed Myeloma Trial

3 ARTICLES

last mo.

Engineered Trays Double Speed to Produce Centimeter-Scale, Self‑Innervated Human Gut Organoids

3 ARTICLES

last mo.

Imfinzi With Enfortumab Vedotin Improves Survival in Phase III Bladder Cancer Trial

4 ARTICLES

last mo.

Inhibrx Combo Shows 44% Response vs 21% With Pembrolizumab Alone in First-Line Head and Neck Cancer

5 ARTICLES

last mo.

NIHR Backs UK Trial Testing Two Cochlear Implants for Adults

7 ARTICLES

last mo.

Harvard Study Finds OpenAI’s o1 Model Outdiagnoses ER Physicians on Text-Only Cases

8 ARTICLES

2mo ago

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Clinical Trials

University of Minnesota Wins $2.2M NEI Grant to Study Fibulin-3 in Retinal Disease

Remote Monitoring Fails to Cut Readmissions After Sepsis and Raises Risk for Older Adults

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

Novartis Says Del‑brax Study Met Endpoints and Reinforced Phase 3 Dosing

Tango’s PRMT5 Inhibitor Plus Daraxonrasib Shows 92% Response in Biomarker‑Selected Pancreatic Cancer

CagriSema Combo Lowers Blood Sugar and Drives Bigger Weight Loss Than Semaglutide Alone

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

Cervical Spinal Stimulation Restores Arm Strength in Small Stroke Trial

CAR‑T Therapy Lets Highly Sensitized Patients Receive Kidney Transplants

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Never miss stories about

Clinical Trials

Phase 1 TCER IMA401 Shows Early Safety and Tumor Responses in Solid Cancers

Selpercatinib Dramatically Cuts Recurrence in Early-Stage RET-Positive Lung Cancer

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

Teclistamab Significantly Lengthens Remissions and Survival in Relapsed Myeloma Trial

Engineered Trays Double Speed to Produce Centimeter-Scale, Self‑Innervated Human Gut Organoids

Imfinzi With Enfortumab Vedotin Improves Survival in Phase III Bladder Cancer Trial

Inhibrx Combo Shows 44% Response vs 21% With Pembrolizumab Alone in First-Line Head and Neck Cancer

NIHR Backs UK Trial Testing Two Cochlear Implants for Adults

Harvard Study Finds OpenAI’s o1 Model Outdiagnoses ER Physicians on Text-Only Cases

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Never miss stories about

Clinical Trials